Collegium Pharmaceutical COLL
NASDAQ COLL
$22.02 +0.18 (+0.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Collegium Pharmaceutical (COLL) Return on Sales [ROS] (2016 - 2026)

Updated

Collegium Pharmaceutical (COLL) posted Return on Sales [ROS] of 1.85% for Q2 2026, down 16.82 percentage points from 18.67% a year earlier and down 14.12 percentage points from the prior quarter.

Analysis

Collegium Pharmaceutical (COLL) Return on Sales [ROS] (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Collegium Pharmaceutical was 19.48%, up 1.13 percentage points year-over-year; for FY2025, it was 23.01%, down 3.89 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +4.88 percentage points (FY2020 to FY2025).
  • In prior years, Collegium Pharmaceutical's Return on Sales [ROS] was 26.91% in FY2024 (-2.55 pp), 29.46% in FY2023 (+22.28 pp), 7.18% in FY2022 (+0.81 pp) and 6.37% in FY2021 (-11.77 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q1 2022.
  • On a year-over-year basis, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -7.99 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2022, with a gain of 133.78 percentage points; the weakest was Q4 2021, with a drop of 144.37 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 15.97% (Q1 2026), 29.57% (Q4 2025) and 29.66% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Collegium Pharmaceutical 709.11 Mn -514.65 Mn 110.29 Mn 1.85%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.85%
Mar 31, 2026 15.97%
Dec 31, 2025 29.57%
Sep 30, 2025 29.66%
Jun 30, 2025 18.67%
Mar 31, 2025 12.20%
Dec 31, 2024 20.95%
Sep 30, 2024 21.87%
Jun 30, 2024 32.68%
Mar 31, 2024 34.14%
Dec 31, 2023 41.20%
Sep 30, 2023 32.93%
Jun 30, 2023 26.29%
Mar 31, 2023 17.01%
Dec 31, 2022 9.07%
Sep 30, 2022 16.11%
Jun 30, 2022 8.99%
Mar 31, 2022 -11.96%
Dec 31, 2021 -124.71%
Sep 30, 2021 17.95%
API Access

Collegium Pharmaceutical Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=COLL&period=max&api_key=YOUR_API_KEY